| Repurposing of drugs targeting YAP-TEAD functions GM Elisi, M Santucci, D D’arca, A Lauriola, G Marverti, L Losi, L Scalvini, ... Cancers 10 (9), 329, 2018 | 44 | 2018 |
| Chiral Recognition of Flexible Melatonin Receptor Ligands Induced by Conformational Equilibria GM Elisi, A Bedini, L Scalvini, C Carmi, S Bartolucci, V Lucini, F Scaglione, ... Molecules 25 (18), 4057, 2020 | 10 | 2020 |
| New classes of potent heparanase inhibitors from ligand-based virtual screening D Pala, L Scalvini, GM Elisi, A Lodola, M Mor, G Spadoni, FF Ferrara, ... Journal of enzyme inhibition and medicinal chemistry 35 (1), 1685-1696, 2020 | 9 | 2020 |
| In silico drug discovery of melatonin receptor ligands with therapeutic potential GM Elisi, L Scalvini, A Lodola, A Bedini, G Spadoni, S Rivara Expert Opinion on Drug Discovery 17 (4), 343-354, 2022 | 7 | 2022 |
| Free-energy simulations support a lipophilic binding route for melatonin receptors GM Elisi, L Scalvini, A Lodola, M Mor, S Rivara Journal of chemical information and modeling 62 (1), 210-222, 2021 | 7 | 2021 |
| N‐(Anilinoethyl)amide Melatonergic Ligands with Improved Water Solubility and Metabolic Stability F Ferlenghi, M Mari, G Gobbi, GM Elisi, M Mor, S Rivara, F Vacondio, ... ChemMedChem 16 (19), 3071-3082, 2021 | 6 | 2021 |
| An Optimized Workflow for the Discovery of New Antimicrobial Compounds Targeting Bacterial RNA Polymerase Complex Formation A Caputo, S Sartini, E Levati, I Minato, GM Elisi, A Di Stasi, C Guillou, ... Antibiotics 11 (10), 1449, 2022 | 3 | 2022 |
| Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence A Bedini, GM Elisi, F Fanini, M Retini, L Scalvini, S Pasquini, C Contri, ... Journal of Pineal Research 76 (2), e12941, 2024 | 2 | 2024 |
| 2-Arylmelatonin analogues: Probing the 2-phenyl binding pocket of melatonin MT1 and MT2 receptors M Mari, GM Elisi, A Bedini, S Lucarini, M Retini, V Lucini, F Scaglione, ... European Journal of Medicinal Chemistry 243, 114762, 2022 | 2 | 2022 |
| Identification of a Quinone Derivative as a YAP/TEAD Activity Modulator from a Repurposing Library A Lauriola, E Uliassi, M Santucci, ML Bolognesi, M Mor, L Scalvini, ... Pharmaceutics 14 (2), 391, 2022 | 2 | 2022 |
| Development of a novel class of YAP: TEAD interface-3 molecular disruptors to treat colorectal carcinoma L Tagliazucchi, G Malpezzi, D Aiello, D Zappaterra, G Elisi, A Venturelli, ... Paul Erhlich MedChem 2023 Congress, 2023 | | 2023 |
| Free-energy simulations applied to melatonin receptor ligands GM Elisi Università degli Studi di Parma. Dipartimento di Scienze degli alimenti e …, 2023 | | 2023 |
Marco MorUniversity of Parma, Università degli Studi di ParmaVerified email at unipr.it
